NPXe
Safeguarding the Brain
NPXe is a late clinical-stage pharmaceutical and drug delivery device company developing xenon gas to protect against brain cell death following acute neurologic injury. Our initial product is xenon in combination with hypothermia for Post Cardiac Arrest Syndrome patients.
NeuroproteXeon Limited and NeuroproteXeon, Inc are wholly owned subsidiaries of NPXe Limited.